EU strengthens partnership with WHO to boost local manufacturing and access to vaccines, medicines and health technologies in Africa

March 28, 2022
Share on

The European Commission and the World Health Organization (WHO) are strengthening their partnership to improve equitable access to safe, effective, and quality-assured vaccines, medicines and health technologies in Sub-Saharan Africa, Commissioner for International Partnerships Jutta Urpilainen and WHO Director-General Dr. Tedros Adhanom Ghebreyesus announced in Geneva.

Commissioner Urpilainen said: “The European Union and WHO share a common ambition to boost local production capacity and access to quality, safe, effective and –importantly – affordable medicines and vaccines. Under the Team Europe initiative for local manufacturing in Africa, today with Dr. Tedros we agreed on stepping up support to our African partners in tackling some of the main barriers to access and availability, with concrete projects financed with at least €24.5 million from the EU budget. Together, we are strengthening the foundations of resilient health systems, universal health coverage and health security for now and in the future.”

The EU–WHO partnership will assist the African Union in reaching its target of increasing local vaccine production, in Africa and for Africa. It will also support the achievement of African Union objectives in areas such as jobs and growth, trade, and scientific cooperation.

The financial contribution of €24.5 million from the EU supports three main categories of action: regulatory strengthening (€11.5 million), technology transfer (€12 million), and demand consolidation and strategic purchasing (€1 million).

For more information

Press release

Countries covered:

  • Algeria
  • Egypt
  • Libya
  • Morocco
  • Tunisia